Immunization with oxidized MART or PMEL vaccines prior to challenge with viable melanoma cells correlated with significant changes in cytokine secretion and altered T‐cell differentiation of tumor‐infiltrated immune cells. The gene discussed is SEPTIN4; the disease is neoplasm.